VIM and neoplasm: Among the vimentin positive tumors, 48.3% (43/89) had a tumor size > 2 cm compared to 25.9% (15/58) of vimentin positive immune-expression in tumors of size less than 2 cm which was (p = 0.009; χ2 = 9.394).